AREV Life Sciences Global 관리

관리 기준 확인 1/4

AREV Life Sciences Global CEO는 Mike Withrow, Oct2018 에 임명되었습니다 의 임기는 6.92 년입니다. 는 CA$ 1.24M 가치에 해당하는 회사 주식의 43.44% 직접 소유합니다. 1.24M. 경영진과 이사회의 평균 재임 기간은 각각 3.8 년과 2.5 년입니다.

주요 정보

Mike Withrow

최고 경영자

n/a

총 보상

CEO 급여 비율	n/a
CEO 임기	5yrs
CEO 소유권	43.4%
경영진 평균 재임 기간	3.8yrs
이사회 평균 재임 기간	2.5yrs

최근 관리 업데이트

Recent updates

How Much Are AREV NanoTec Brands Inc. (CSE:AREV) Insiders Taking Off The Table?

Jan 02

CEO

Mike Withrow

5yrs

테뉴어

Mr. Michael Withrow, also known as Mike, serves as Director at AREV Life Sciences Global Corp. (formerly known as AREV NanoTec Brands Inc.) (formerly known as AREV Brands International Ltd.) (formerly, ARE...

리더십 팀

이름	위치	테뉴어	보상	소유권
Michael Withrow	Chairman & CEO	5yrs	데이터 없음	43.44% CA$ 1.2m
Denby Greenslade	Interim CFO	3.8yrs	CA$72.00k	1.15% CA$ 33.0k
Donald Shaxon	Vice President of Marketing	2.8yrs	데이터 없음	데이터 없음

3.8yrs

평균 재임 기간

경험이 풍부한 관리: AREV 의 관리팀은 경험 ( 3.8 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Michael Withrow	Chairman & CEO	6.9yrs	데이터 없음	43.44% CA$ 1.2m
Denby Greenslade	Interim CFO	3.8yrs	CA$72.00k	1.15% CA$ 33.0k
Kevin Phelps	Director	2.7yrs	CA$18.24k	데이터 없음
Harold Smith	Member of Scientific Advisory Board	2.3yrs	데이터 없음	데이터 없음
Roscoe Moore	Chairman of Scientific Advisory Board	2.7yrs	데이터 없음	데이터 없음
Douglas Sorocco	Member of Scientific Advisory Board	1.7yrs	데이터 없음	데이터 없음
Uma V. Dhanabalan	Member of Scientific Advisory Board	2.7yrs	데이터 없음	데이터 없음
Jay Noller	Member of Scientific Advisory Board	2.7yrs	데이터 없음	데이터 없음
Richard Van Breemen	Member of Scientific Advisory Board	2.3yrs	데이터 없음	데이터 없음
Allan Echino	Director	1.8yrs	데이터 없음	2.42% CA$ 69.1k
Brian Elliott	Director	1.6yrs	데이터 없음	데이터 없음
Sateesh Apte	Member of Scientific Advisory Board	1.2yrs	데이터 없음	데이터 없음

2.5yrs

평균 재임 기간

경험이 풍부한 이사회: AREV 의 이사회는 경험(평균 재직 기간 2.5 년)으로 간주되지 않으므로 새 이사회가 필요합니다.

AREV Life Sciences Global 관리

관리 기준 확인 1/4

주요 정보

최근 관리 업데이트

AREV Life Sciences Global Corp., Annual General Meeting, Apr 05, 2024

No independent directors

No independent directors

No independent directors

AREV Life Sciences Global Corp. Announces the Resignation of Melvin Maxwell from Board

No independent directors

Recent updates

AREV Life Sciences Global Corp., Annual General Meeting, Apr 05, 2024

No independent directors

No independent directors

No independent directors

AREV Life Sciences Global Corp. Announces the Resignation of Melvin Maxwell from Board

No independent directors

Third quarter 2022 earnings released: CA$0.008 loss per share (vs CA$0.009 loss in 3Q 2021)

Chairman & CEO recently bought CA$59k worth of stock

No independent directors

AREV Life Sciences Global Corp. Announces Management Changes

Second quarter 2022 earnings released: CA$0.026 loss per share (vs CA$0.028 loss in 2Q 2021)

AREV Life Sciences Global Corp. Announces the Appointment of Sateesh Apte to the Scientific Advisory Board

Full year 2021 earnings released: CA$0.051 loss per share (vs CA$0.068 loss in FY 2020)

No independent directors

AREV Life Sciences Global Corporation Appoints Brian V. Elliott to its Board of Directors

AREV Life Sciences Global Corp. Appoints Kevin Phelps as Chief Operating Officer

AREV Life Sciences Global Corp. Appoints Douglas Sorocco to Its Scientific Advisory Committee

AREV Life Sciences Settles Pending Litigation with Harvey

Third quarter 2021 earnings: Revenues and EPS in line with analyst expectations

AREV Life Sciences Global Corp. (CNSX:AREV) acquired Wright and Well Essentials Inc. for CAD 0.02 million.

Chairman & CEO exercised options to buy CA$200k worth of stock.

Chairman & CEO recently sold CA$125k worth of stock

Second quarter 2021 earnings released: CA$0.028 loss per share (vs CA$0.017 loss in 2Q 2020)

First quarter 2021 earnings released: CA$0.026 loss per share (vs CA$0.012 loss in 1Q 2020)

AREV NanoTec Brands Inc. Expands Extraction Results to Clinical Characterization of Compounds, Development of Advanced-Stage Therapeutic Foods and Discovery of Plant-Based Drugs

AREV NanoTec Brands Inc. announced that it has received CAD 0.67 million in funding

Arev Nanotec Brands Inc. Appoints Chad S. Johnson, Esq. as Special Counsel for Corporate Development

AREV NanoTec Brands Inc. Announces Addition of Kevin J. Phelps to its Board of Directors

AREV NanoTec Brands Inc. Appoints Dr. Jay Noller to its Scientific Advisory Board

AREV’s Nanotech Initiates Early-Stage Antiviral Photochemistry Derivation Discovery Program for Pandemic Viral Pathogens

New 90-day high: CA$0.42

AREV Appoints Dr. Roscoe Moore to Join the Advisory Board

AREV NanoTec Brands Inc. Corporate Update on Latest Innovation

AREV NanoTec Brands Inc. Appoints Dr. Uma V. A. Dhanabalan as Advisory Board

AREV NanoTec Brands Inc. announced that it expects to receive CAD 0.725 million in funding

AREV NanoTec Brands Inc. announced that it has received CAD 0.1 million in funding from Chiron Partners LLC

How Much Are AREV NanoTec Brands Inc. (CSE:AREV) Insiders Taking Off The Table?

New 90-day high: CA$0.22

Chairman & CEO recently sold CA$261k worth of stock

AREV NanoTec Brands Inc. Receives Its First Trial Run of Its Naturvac Immune Boost

AREV NanoTec Brands Inc. Appoints Don Shaxon to the Position of VP Marketing

First half earnings released

AREV Brands International Ltd. (CNSX:AREV) cancelled the acquisition of 5,300 square foot facility and a 100 acre cannabis and hemp cultivation in California.

AREV NanoTec Brands Inc. announced that it expects to receive CAD 0.16 million in funding

CEO

테뉴어

리더십 팀

평균 재임 기간

이사회 구성원

평균 재임 기간